Historical Annual Stock Price Data | ||||||
---|---|---|---|---|---|---|
Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
2024 | 0.4755 | 0.7846 | 0.7846 | 0.1676 | 0.1950 | -74.68% |
2023 | 1.1459 | 1.5500 | 2.0700 | 0.4911 | 0.7700 | -49.67% |
2022 | 2.8242 | 6.3300 | 6.3300 | 1.3500 | 1.5300 | -75.04% |
2021 | 14.7851 | 18.6100 | 30.5400 | 6.0800 | 6.1300 | -66.21% |
2020 | 10.6836 | 1.8100 | 27.8000 | 1.2900 | 18.1400 | 936.57% |
2019 | 3.6530 | 11.1900 | 11.7900 | 1.2200 | 1.7500 | -83.94% |
2018 | 13.6997 | 13.3500 | 16.9000 | 10.2700 | 10.9000 | -18.35% |
2017 | 16.6757 | 19.1000 | 19.5500 | 12.4000 | 13.3500 | -27.84% |
2016 | 19.4156 | 18.4800 | 24.9900 | 15.6500 | 18.5000 | 10.65% |
2015 | 17.6349 | 14.9700 | 22.8100 | 14.1300 | 16.7200 | 10.14% |
2014 | 10.9299 | 8.2200 | 15.1800 | 7.9500 | 15.1800 | 80.07% |
2013 | 7.1667 | 3.7300 | 9.7700 | 3.7300 | 8.4300 | 140.17% |
2012 | 2.8155 | 1.8700 | 3.9500 | 1.8100 | 3.5100 | 100.57% |
2011 | 2.1474 | 1.9300 | 3.2400 | 1.3900 | 1.7500 | -1.69% |
2010 | 2.1765 | 2.0900 | 4.3500 | 1.2700 | 1.7800 | -12.32% |
2009 | 1.4700 | 2.1800 | 2.8900 | 0.4700 | 2.0300 | -8.14% |
2008 | 4.2028 | 4.9200 | 6.7300 | 1.6800 | 2.2100 | -54.43% |
2007 | 11.2352 | 13.7130 | 18.1861 | 4.4700 | 4.8500 | -64.51% |
2006 | 14.5554 | 17.2609 | 18.7350 | 11.0582 | 13.6642 | -23.00% |
2005 | 22.0815 | 21.5695 | 27.9206 | 16.0056 | 17.7459 | -21.40% |
2004 | 17.0571 | 12.8642 | 23.5873 | 12.1982 | 22.5784 | 76.14% |
2003 | 11.8018 | 12.6236 | 14.4282 | 9.1391 | 12.8186 | 8.39% |
2002 | 25.2322 | 26.0617 | 40.2345 | 11.2426 | 11.8269 | -57.18% |
2001 | 20.6227 | 12.5430 | 29.5141 | 10.9692 | 27.6197 | 109.18% |
2000 | 11.4242 | 7.3285 | 18.2951 | 5.7049 | 13.2040 | 81.41% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
$0.000B | $0.000B | ||
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Brookfield Reinsurance (BNT) | Bermuda | $6.731B | 154.23 |
RDE (GIFT) | United States | $0.075B | 0.00 |
InFinT Acquisition (CURR) | $0.034B | 0.00 | |
ARCA Biopharma (ORKA) | United States | $0.030B | 0.00 |